Full name
LABS212 SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
10.89.Z - Production of other food products, not elsewhere classified
10.86.Z - Production of homogenized food products and diet food
20.53.Z - Manufacture of chemicals and chemical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.78.Z - Retail sale of other new products
47.91.Z - Intermediary retail sale, non-specialized
72.11.Z - Scientific research and development activities
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,4 | 0,1 | -79,7 | |
Gross profit (loss) | 0,2 | 0,4 | 0,1 | -85,7 |
EBITDA | 0,2 | 0,4 | 0,1 | -80,6 |
Short time liabilities | 0,3 | 0,8 | 1,2 | 55,6 |
Other operating costs | 0 | 0 | -51,5 | |
Equity capital | 0,3 | 0,6 | 0,7 | 8,8 |
Operating profit (EBIT) | 0,2 | 0,4 | 0,1 | -80,6 |
Assets | 0,5 | 1,4 | 1,9 | 35,1 |
Net profit (loss) | 0,2 | 0,3 | 0,1 | -84,2 |
Cash | 0 | 0 | 0 | 1582,9 |
Liabilities and provisions for liabilities | 0,3 | 0,8 | 1,2 | 55,6 |
Net income from sale | 1 | 1,7 | 2 | 12,5 |
Working assets | 0,5 | 1,4 | 1,5 | 10,1 |
Other income costs | 0 | 0 | 424,2 | |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 84 | 55,3 | 8 | -47,3 |
Equity capital to total assets | 50,3 | 43,8 | 35,3 | -8,5 |
Gross profit margin | 22,5 | 21,2 | 2,7 | -18,5 |
EBITDA Margin | 22,9 | 21,9 | 3,8 | -18,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 90 | 163 | 225 | 62 |
Current financial liquidity indicator | 1.7800977230072021 | 1.2600822448730469 | -0,5 | |
Net dept to EBITDA | 1.3213129043579102 | -0.03472653403878212 | -1,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane